Cold Atmospheric Plasma Device Extension Study

PHASE3RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 18, 2023

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2026

Conditions
Verruca VulgarisMolluscum Contagiosum
Interventions
DEVICE

Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP)

The treatment device in this study generates cold atmospheric plasma. Cold atmospheric plasma has certain properties of plasma, such as ionized gas molecules. To create plasma, a pulse generator supplying 20 kilovolt pulse of 20-ns pulse width at 200 Hz (FPG10-01NM10, FID GmbH, Burbach, Germany) to a 5-mm diameter quartz-covered copper electrode of 10-cm length and 1 - 13mm quartz thickness. These nanosecond pulse parameters were chosen to provide sufficient treatment dose at the high level of plasma uniformity required to avoid any tissue damage. We will treat the lesions for approximately 1 to 2 minutes each, moving the electrode gently over the treatment area.

Trial Locations (1)

29425

RECRUITING

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

The Skin Center Dermatology Group

INDUSTRY

lead

Medical University of South Carolina

OTHER